6,186 Astera Labs, Inc. $ALAB Shares Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 470.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,500 shares of the company’s stock after acquiring an additional 6,186 shares during the period. Jefferies Financial Group Inc.’s holdings in Astera Labs were worth $2,670,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in ALAB. Illinois Municipal Retirement Fund grew its holdings in shares of Astera Labs by 19.1% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 32,819 shares of the company’s stock worth $11,683,000 after purchasing an additional 5,258 shares during the period. Lido Advisors LLC boosted its stake in shares of Astera Labs by 114.8% in the 3rd quarter. Lido Advisors LLC now owns 27,630 shares of the company’s stock valued at $9,836,000 after buying an additional 14,768 shares during the period. Keybank National Association OH raised its holdings in shares of Astera Labs by 139.8% in the 3rd quarter. Keybank National Association OH now owns 2,103 shares of the company’s stock valued at $749,000 after purchasing an additional 1,226 shares in the last quarter. Csenge Advisory Group purchased a new position in shares of Astera Labs in the 3rd quarter valued at about $534,000. Finally, 71 West Capital Partners purchased a new stake in shares of Astera Labs during the 3rd quarter worth approximately $208,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Morgan Stanley increased their price objective on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a report on Wednesday, November 4th. Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 target price for the company in a report on Wednesday, November 4th. Barclays lifted their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Finally, Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $320.85.

Check Out Our Latest Analysis on ALAB

Key Headlines Impacting Astera Labs

These are some of the ALAB headlines that stood out recently:

  • Positive Sentiment: Strong demand for PCIe connectivity and AI infrastructure is supporting Astera Labs’ Aries and Scorpio products, providing potential growth opportunities. ALAB Benefits From Strong PCIe Demand
  • Neutral Sentiment: Astera Labs presented at the BMO Capital Technology and Innovation Leaders Conference; the available report is a transcript and does not identify a specific new catalyst. BMO Capital Conference Transcript
  • Negative Sentiment: Recent coverage describes a mixed trading picture: record Q3 growth is being offset by heavier selling pressure. It also flags competition from Marvell and Credo, which could challenge Astera Labs’ growth. Mixed Trading After Record Q3 Growth

Insiders Place Their Bets

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares of the company’s stock, valued at $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 220,497 shares of company stock worth $62,043,303. Insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $221.83 on Monday. The company has a market cap of $38.77 billion, a price-to-earnings ratio of 88.38 and a beta of 3.86. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock’s 50-day moving average is $294.27 and its 200-day moving average is $257.09.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The business had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The company’s revenue for the quarter was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.99 EPS for the current year.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.